LGM Pharma Revenue and Competitors

Miami, FL USA



Total Funding



Estimated Revenue & Valuation

  • LGM Pharma's estimated annual revenue is currently $28.1M per year.(i)
  • LGM Pharma's estimated revenue per employee is $201,000

Employee Data

  • LGM Pharma has 140 Employees.(i)
  • LGM Pharma grew their employee count by 5% last year.

LGM Pharma's People

Co-Founder and Consultant at LGM PharmaReveal Email/Phone
Executive Assistant to CEO & Senior Leadership TeamReveal Email/Phone
CEOReveal Email/Phone
VP Project ManagementReveal Email/Phone
SVP - Business Development & OperationsReveal Email/Phone
VP Supply Chain and Sales OperationsReveal Email/Phone
SVP Sourcing and ProcurementReveal Email/Phone
VP - Business DevelopmentReveal Email/Phone
Director OperationsReveal Email/Phone
Marketing ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

What Is LGM Pharma?

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical industry. We secure and optimize your supply chain with our extensive qualified API partner network, global drug product development and manufacturing facilities, and regulatory and market intelligence services delivering customized solutions that get your products to market faster. Full-service, expert support that accelerates the new product pathway. Now that's smart. • Established in 2005 • ISO 9001-2015 QMS certified company • CGMP systems in accordance with ICH Q7 • Main business segments: R&D / Biotech / CDMO / Specialty Pharma Companies, New Drug Delivery Technologies (NDA/505b2) – with heavy concentration on injectables, transdermal, nasal, inhalation, ophthalmic & sublingual drug deliveries Our products originate from our API manufacturing partner sites who are approved by the leading regulatory authorities, such as the US-FDA, EDQM, TGA, UK-MHRA, PMDA etc. LGM's industry experience enables us to support our clients throughout the entire pathway of drug development, from discovery through commercial production. Based on the scale and scope of development projects with which we are involved, we are able to provide our customers with a seasoned perspective and valuable market insight. LGM Pharma has enhanced its position as a leading supplier of newly approved APIs, including full technical documentation and regulatory support. Our Clients: At LGM Pharma, our clients' needs are our top priority, and we support our client base consisting of a diverse array of pharma companies, including: • Contract Research, Development & Manufacturing Organizations • Specialty Pharma and Novel Drug Delivery Systems • R&D & Biotech Companies • Generic Pharma Companies • Chemical Catalog Companies • OTC & Private Label Manufacturers • Academic & Government Laboratories • Pharmacy Compounding Industry



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





LGM Pharma News

2022-04-20 - Aliskiren Market Size, Scope And Outlook | Noden Pharma ...

Noden Pharma, LGM Pharma, Cayman, Vitae-GSK, Daiichi Sankyo, Novartis, Merck-Frost, Mitsubishi-Tanabe, Takeda, Cadila Healthcare.

2022-04-20 - Cisapride Market Size, Outlook And Forecast | LGM Pharma ...

LGM Pharma, Toronto Research Chemicals, Alfa Chemistry, 3B Scientific, Waterstone Technology, 2A PharmaChem, EDQM, J & K SCIENTIFIC,...

2017-12-06 - New Harbor Capital Acquires LGM Pharma

Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce a majority acquisition of its client, LGM Pharma, by New Harbor Capital LLC. The transaction closed November 15, 2017. LGM specializes in streamlining the API supply chain throu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding